These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 11514498)

  • 41. Isolated eosinophilic coronary arteritis and eosinophilic myocarditis. A limited form of Churg-Strauss syndrome.
    Lie JT; Bayardo RJ
    Arch Pathol Lab Med; 1989 Feb; 113(2):199-201. PubMed ID: 2916909
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Churg Strauss syndrome during treatment of bronchial asthma with a leucotriene receptor antagonist presenting with polyneuropathy.
    Oberndorfer S; Beate U; Sabine U; Peter H; Heinz L; Barabra H; Wolfgang G
    Neurologia; 2004 Apr; 19(3):134-8. PubMed ID: 15088164
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A life-threatening presentation of eosinophilic granulomatosis with polyangiitis.
    Ammirati E; Cipriani M; Musca F; Bonacina E; Pedrotti P; Roghi A; Astaneh A; Schroeder JW; Nonini S; Russo CF; Oliva F; Frigerio M
    J Cardiovasc Med (Hagerstown); 2016 Dec; 17 Suppl 2():e109-e111. PubMed ID: 26556445
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Churg-Strauss syndrome associated with leukotriene receptor antagonists (LTRA).
    Cuchacovich R; Justiniano M; Espinoza LR
    Clin Rheumatol; 2007 Oct; 26(10):1769-71. PubMed ID: 17256102
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The relationship of asthma therapy and Churg-Strauss syndrome: NIH workshop summary report.
    Weller PF; Plaut M; Taggart V; Trontell A
    J Allergy Clin Immunol; 2001 Aug; 108(2):175-83. PubMed ID: 11496231
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Churg-Strauss and montelukast.
    Carlesimo M; Mari E; Palese E; Pranteda G; Camplone G
    Int J Immunopathol Pharmacol; 2011; 24(4):1079-82. PubMed ID: 22230414
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fatal carbamazepine induced fulminant eosinophilic (hypersensitivity) myocarditis: emphasis on anatomical and histological characteristics, mechanisms and genetics of drug hypersensitivity and differential diagnosis.
    Arsenovic N; Sheehan L; Clark D; Moreira R
    J Forensic Leg Med; 2010 Feb; 17(2):57-61. PubMed ID: 20129423
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Acute necrotizing eosinophilic myocarditis successfully treated by high dose methylprednisolone.
    Watanabe N; Nakagawa S; Fukunaga T; Fukuoka S; Hatakeyama K; Hayashi T
    Jpn Circ J; 2001 Oct; 65(10):923-6. PubMed ID: 11665801
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Eosinophilic explant carditis with eosinophilia: ?Hypersensitivity to dobutamine infusion.
    Spear GS
    J Heart Lung Transplant; 1995; 14(4):755-60. PubMed ID: 7578186
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antileukotriene drugs in the treatment of asthma.
    Mastalerz L; Kumik J
    Pol Arch Med Wewn; 2010 Mar; 120(3):103-8. PubMed ID: 20332717
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Acute necrotizing eosinophilic myocarditis in a patient taking Garcinia cambogia extract successfully treated with high-dose corticosteroids.
    Allen SF; Godley RW; Evron JM; Heider A; Nicklas JM; Thomas MP
    Can J Cardiol; 2014 Dec; 30(12):1732.e13-5. PubMed ID: 25475477
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The position of pranlukast, a cysteinyl leukotriene receptor antagonist, in the long-term treatment of asthma. 5-year follow-up study.
    Obase Y; Shimoda T; Matsuse H; Kondo Y; Machida I; Kawano T; Saeki S; Tomari S; Mitsuta-Izaki K; Matsuo N; Fukushima C; Kohno S
    Respiration; 2004; 71(3):225-32. PubMed ID: 15133341
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Churg-Strauss syndrome may be induced by leukotriene modifiers in severe asthma.
    Choi IS; Koh YI; Joo JY; Lee SH; Bae WG
    Ann Allergy Asthma Immunol; 2003 Jul; 91(1):98. PubMed ID: 12877461
    [No Abstract]   [Full Text] [Related]  

  • 54. Clinical significance of corticosteroid therapy for eosinophilic myocarditis.
    Yanagisawa T; Inomata T; Watanabe I; Maekawa E; Mizutani T; Shinagawa H; Koitabashi T; Takeuchi I; Izumi T
    Int Heart J; 2011; 52(2):110-3. PubMed ID: 21483171
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of switching low-dose inhaled corticosteroid to pranlukast for step-down therapy in well-controlled patients with mild persistent asthma.
    Harada S; Harada N; Itoigawa Y; Katsura Y; Kasuga F; Ishimori A; Makino F; Ito J; Atsuta R; Takahashi K
    J Asthma; 2016; 53(2):207-12. PubMed ID: 26325232
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of theophylline or pranlukast, a cysteinyl leukotriene receptor 1 antagonist, as add-on therapy in uncontrolled asthmatic patients with a medium dose of inhaled corticosteroids.
    Tsuchida T; Matsuse H; Machida I; Kondo Y; Saeki S; Tomari S; Obase Y; Matsuo N; Shimoda T; Kohno S
    Allergy Asthma Proc; 2005; 26(4):287-91. PubMed ID: 16270722
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Leukotriene E(4)-induced persistent eosinophilia and airway obstruction are reversed by zafirlukast in patients with asthma.
    Laitinen A; Lindqvist A; Halme M; Altraja A; Laitinen LA
    J Allergy Clin Immunol; 2005 Feb; 115(2):259-65. PubMed ID: 15696079
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical evaluation of response to long-term treatment with Pranlukast in patients with bronchial asthma.
    Niitsuma T; Izawa J; Maruoka N; Nukaga M; Tsuji A; Okita M; Sakurai K; Morita S; Tsuyuguchi M; Matsumura Y; Hayashi T
    J Investig Allergol Clin Immunol; 2004; 14(4):284-91. PubMed ID: 15736713
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of the leukotriene receptor antagonist pranlukast on cellular infiltration in the bronchial mucosa of patients with asthma.
    Nakamura Y; Hoshino M; Sim JJ; Ishii K; Hosaka K; Sakamoto T
    Thorax; 1998 Oct; 53(10):835-41. PubMed ID: 10193369
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy and safety of long-term treatment of asthmatic patients with pranlukast, a cysteinyl-leukotriene-receptor antagonist: four-year followup study.
    Obase Y; Shimoda T; Tomari S; Mitsuta K; Fukushima C; Kawano T; Matsuse H; Kohno S
    Ann Allergy Asthma Immunol; 2001 Jul; 87(1):43-7. PubMed ID: 11476461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.